GRADE IV ASTROCYTOMA

Clinical trials for GRADE IV ASTROCYTOMA explained in plain language.

Never miss a new study

Get alerted when new GRADE IV ASTROCYTOMA trials appear

Sign up with your email to follow new studies for GRADE IV ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug targets deadly brain cancer in early trial

Disease control Recruiting now

This study tests a new drug called LMP744 in 40 adults whose glioblastoma (a type of brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days each month for up to a year. The goal is to see if it can shrink tumors or slow their growth.

Matched conditions: GRADE IV ASTROCYTOMA

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated May 25, 2026 00:43 UTC

GRADE IV ASTROCYTOMA

Get alerted when new GRADE IV ASTROCYTOMA trials appear

New drug targets deadly brain cancer in early trial